Literature DB >> 28503559

Cell-free DNA methylation as liquid biopsy for the assessment of fibrosis in patients with nonalcoholic steatohepatitis: a gap between innovation and implementation.

Silvia Sookoian1, Carlos J Pirola1,2.   

Abstract

Entities:  

Year:  2017        PMID： 28503559      PMCID： PMC5411270          DOI： 10.21037/hbsn.2017.01.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  19 in total

1.  Acute exercise remodels promoter methylation in human skeletal muscle.

Authors:  Romain Barrès; Jie Yan; Brendan Egan; Jonas Thue Treebak; Morten Rasmussen; Tomas Fritz; Kenneth Caidahl; Anna Krook; Donal J O'Gorman; Juleen R Zierath
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

2.  Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.

Authors:  Silvia Sookoian; Maria Soledad Rosselli; Carolina Gemma; Adriana L Burgueño; Tomas Fernández Gianotti; Gustavo O Castaño; Carlos J Pirola
Journal:  Hepatology       Date:  2010-10-01       Impact factor: 17.425

Review 3.  Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

Authors:  William N Hannah; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2016-05       Impact factor: 3.199

Review 4.  The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Clin Liver Dis       Date:  2012-06-20       Impact factor: 6.126

5.  Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.

Authors:  Kun Sun; Peiyong Jiang; K C Allen Chan; John Wong; Yvonne K Y Cheng; Raymond H S Liang; Wai-kong Chan; Edmond S K Ma; Stephen L Chan; Suk Hang Cheng; Rebecca W Y Chan; Yu K Tong; Simon S M Ng; Raymond S M Wong; David S C Hui; Tse Ngong Leung; Tak Y Leung; Paul B S Lai; Rossa W K Chiu; Yuk Ming Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

6.  Mitochondrial genome architecture in non-alcoholic fatty liver disease.

Authors:  Silvia Sookoian; Diego Flichman; Romina Scian; Cristian Rohr; Hernán Dopazo; Tomas Fernández Gianotti; Julio San Martino; Gustavo O Castaño; Carlos J Pirola
Journal:  J Pathol       Date:  2016-10-18       Impact factor: 7.996

Review 7.  Nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Vincent W-S Wong; Valerio Nobili; Christopher P Day; Silvia Sookoian; Jacquelyn J Maher; Elisabetta Bugianesi; Claude B Sirlin; Brent A Neuschwander-Tetri; Mary E Rinella
Journal:  Nat Rev Dis Primers       Date:  2015-12-17       Impact factor: 52.329

8.  Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.

Authors:  Carlos J Pirola; Tomas Fernández Gianotti; Gustavo O Castaño; Pablo Mallardi; Julio San Martino; María Mora Gonzalez Lopez Ledesma; Diego Flichman; Faridodin Mirshahi; Arun J Sanyal; Silvia Sookoian
Journal:  Gut       Date:  2014-06-27       Impact factor: 23.059

9.  Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes.

Authors:  Katsunori Fujiki; Fumi Kano; Kunio Shiota; Masayuki Murata
Journal:  BMC Biol       Date:  2009-07-10       Impact factor: 7.431

10.  Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.

Authors:  Timothy Hardy; Mujdat Zeybel; Christopher P Day; Christian Dipper; Steven Masson; Stuart McPherson; Elsbeth Henderson; Dina Tiniakos; Steve White; Jeremy French; Derek A Mann; Quentin M Anstee; Jelena Mann
Journal:  Gut       Date:  2016-03-21       Impact factor: 23.059
View more
  5 in total

Review 1.  NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?

Authors:  Shivaram P Singh; Rakesh K Barik
Journal:  J Clin Exp Hepatol       Date:  2019-09-21

Review 2.  Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Pharmaceut Med       Date:  2019-12

Review 3.  Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity.

Authors:  Carlos J Pirola; Silvia Sookoian
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

Review 4.  The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Lucia Carulli; Giulia Zanca; Filippo Schepis; Erica Villa
Journal:  Metabolites       Date:  2019-02-01

5.  Reconsidering the therapeutic use for vacuum-assisted breast biopsy in breast cancer patients: a retrospective single-center study.

Authors:  Jialin Zhao; Xuejing Wang; Ying Xu; Li Peng; Qiang Sun
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.